The study involved 37 polycystic ovary syndrome patients who were referred from the endocrinology department and 26 healthy volunteers. All participants who showed normal otoscopic findings, hearing thresholds, and acoustic admittance were included. All polycystic ovary syndrome patients showed biochemical signs of hyperandrogenism. Cochlear activity of participants was evaluated by means of distortion product otoacoustic emissions and transient otoacoustic emissions